The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-11), Fulgent Genetics's share price is $21.75. Fulgent Genetics's Book Value per Share for the quarter that ended in Mar. 2024 was $37.79. Hence, Fulgent Genetics's PB Ratio of today is 0.58.
Good Sign:
Fulgent Genetics Inc stock PB Ratio (=0.58) is close to 10-year low of 0.53
The historical rank and industry rank for Fulgent Genetics's PB Ratio or its related term are showing as below:
FLGT'
s PB Ratio Range Over the Past 10 Years
Min: 0.53 Med: 1.71 Max: 12.03
Current: 0.58
During the past 10 years, Fulgent Genetics's highest PB Ratio was 12.03. The lowest was 0.53. And the median was 1.71.
FLGT's PB Ratio is ranked better than 89.86% of 207
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.13
vs FLGT: 0.58
During the past 12 months, Fulgent Genetics's average Book Value Per Share Growth Rate was -11.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 23.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 81.90% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Fulgent Genetics was 139.00% per year. The lowest was 7.70% per year. And the median was 89.65% per year.
Back to Basics: PB Ratio
Fulgent Genetics PB Ratio Historical Data
The historical data trend for Fulgent Genetics's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Fulgent Genetics's PB Ratio
For the Diagnostics & Research subindustry, Fulgent Genetics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fulgent Genetics's PB Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's PB Ratio distribution charts can be found below:
* The bar in red indicates where Fulgent Genetics's PB Ratio falls into.
Fulgent Genetics PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Fulgent Genetics PB Ratio Related Terms
Thank you for viewing the detailed overview of Fulgent Genetics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Fulgent Genetics (Fulgent Genetics) Business Description
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FLGT has been successfully added to your 